BST2
Bone marrow stromal antigen 2
Also known as: BST-2, BST2_HUMAN, CD317, HM1.24, tetherin
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q10589
- Gene
- BST2
- Ensembl
- ENSG00000130303
- Chromosome
- 19
- Canonical length
- 180 aa
- Protein class
- CD markers, Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Vesicles
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Bone marrow stromal cells are involved in the growth and development of B-cells. The specific function of the protein encoded by the bone marrow stromal cell antigen 2 is undetermined; however, this protein may play a role in pre-B-cell growth and in rheumatoid arthritis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
180 residues, UniProt reviewed canonical sequence.
>Q10589|BST2
1 MASTSYDYCR VPMEDGDKRC KLLLGIGILV LLIIVILGVP LIIFTIKANS EACRDGLRAV
61 MECRNVTHLL QQELTEAQKG FQDVEAQAAT CNHTVMALMA SLDAEKAQGQ KKVEELEGEI
121 TTLNHKLQDA SAEVERLRRE NQVLSVRIAD KKYYPSSQDS SSAAAPQLLI VLLGLSALLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BST2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 677 nTPM
Expression across tissuesHPA
Tissue
- ovary: 677 nTPM
- adrenal gland: 501 nTPM
- fallopian tube: 254 nTPM
- spleen: 233 nTPM
- liver: 221 nTPM
- adipose tissue: 219 nTPM
Single-cell type
- ovarian stromal cells: 1,149 nCPM
- hofbauer cells: 528 nCPM
- granulosa cells: 403 nCPM
- peritubular myoid cells: 349 nCPM
- vascular endothelial cells: 337 nCPM
- medullary thymic epithelial cells: 310 nCPM
Immune cell
- plasmacytoid DC: 423 nTPM
- intermediate monocyte: 386 nTPM
- total PBMC: 368 nTPM
- non-classical monocyte: 361 nTPM
- NK-cell: 354 nTPM
- classical monocyte: 346 nTPM
Brain region
- medulla oblongata: 58 nTPM
- spinal cord: 48 nTPM
- thalamus: 35 nTPM
- white matter: 35 nTPM
- pons: 29 nTPM
- basal ganglia: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BST2.
Disease | ImmuneIEDB
Conditions an epitope on BST2 was assayed in.
- melanoma T cell
- skin melanoma T cell
- multiple myeloma T cell
- smoldering myeloma T cell
- extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue T cell
- acute myeloid leukemia T cell
ReferencesPubMed · IEDB
Publications for BST2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Investigation of the mechanism of drug-induced autoimmune hemolytic anemia in cynomolgus monkeys elicited by a repeated-dose of a humanized monoclonal antibody drug.
2003 · J Toxicol Sci · RCR 0.1 · 6 citations
Reference: T cellIEDB
4 publications
- Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy.
2023 · Cell · RCR 9 · 114 citations - Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma.
2020 · Cancer Immunol Res · RCR 1.9 · 51 citations - PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors.
2020 · Clin Cancer Res · RCR 1.4 · 39 citations - T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.
2019 · Cancer Immunol Res · RCR 0.3 · 10 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.41
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell activation
- defense response to virus
- innate immune response
- negative regulation of cell growth
- negative regulation of cell migration
- negative regulation of intracellular transport of viral material
- negative regulation of viral genome replication
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of leukocyte proliferation
- regulation of actin cytoskeleton organization
- response to interferon-alpha
- response to interferon-beta
- response to type II interferon
- response to virus
- negative regulation of plasmacytoid dendritic cell cytokine production
Molecular functions
- identical protein binding
- metalloendopeptidase inhibitor activity
- protein homodimerization activity
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Bone marrow stromal antigen 2
- Bone marrow stromal antigen 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BST2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BST2 as an antibody target. Whether an autoantibody or antibody against BST2 could matter depends on whether native BST2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BST2 is annotated at the cell surface, where native BST2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BST2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...